Pulmonary Vascular Disease News

Remote 6-minute walk testing was consistent with standardized clinic walks and may be valid in pulmonary testing, researchers reported in the American Journal of Respiratory Critical Care Medicine.

Riociguat treatment significantly improved exercise capacity and prevented clinical worsening in patients with sarcoidosis-associated pulmonary hypertension, according to study results published in Chest.

Infections caused by rhinovirus, respiratory syncytial virus and varicella, precede Kawasaki disease outbreaks by 1 to 3 months in children and young adults in South Korea, according to data published in JAMA Network Open.

A new study in Chest highlights a link between elevated heart rate and risk for all-cause and pulmonary embolism-related mortality in patients with acute symptomatic PE.

Individuals with mildly elevated estimated right ventricular systolic pressure had a high burden of mortality and consequential premature deaths, researchers reported in the European Respiratory Journal.

Among pediatric patients in the Pediatric Pulmonary Hypertension Network, nearly half had group 3 disease, defined as pulmonary hypertension associated with lung disease or hypoxia, researchers reported in the European Respiratory Journal.

In this episode, Joel M. Gelfand, MD, MSCE, is joined by Leonard H. Calabrese, DO, and Amesh Adalja, MD, FIDSA, as they discuss quarantine and isolation guidelines, emerging therapies to treat COVID-19, and the anticipated future of the COVID-19 pandemic.

In a new study, researchers reported obstructive sleep apnea is common in patients with pulmonary hypertension, and risk factors include older age, male sex and lower daytime arterial oxygen pressure.

The Healio Editors compiled the most-read pulmonary hypertension news published in 2021.

New data published in Chest support a lower tricuspid regurgitation velocity of 2.7 m per second for pulmonary hypertension screening.